FDA Inspection 1181368 — Jeffrey W. Taub, M.D.
The FDA completed an inspection of Jeffrey W. Taub, M.D. on Oct 12, 2022 in Detroit, MI. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 2 citations were issued during this inspection. Product area: Drugs.
Inspection Details
- Classification
- Official Action Indicated (OAI)
- End Date
- Oct 12, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Detroit, MI (United States)
Additional Details
Clinical Investigator (CI)
Citations
| ID | CFR | Description |
|---|---|---|
| 7517 | 21 CFR 312.66 | Initial and continuing review |
| 7560 | 21 CFR 312.60 | FD-1572, protocol compliance |